Figure 3. The proportion of patients with grades, IDH1 mutation type, and 1p19q codel status in the high or low-risk groups in the TCGA cohort. (A) The proportion of patients with grades mutation type in the high or low-risk groups. (B) The proportion of patients with IDH1 mutation type in the high or low-risk groups. (C) The proportion of patients with 1p19q codel status in the high or low-risk groups. (D) The expression value of 8 lncRNA in glioma tissues and normal brain tissues.